Christof Hettich

Dr. Christof Hettich is Chairman-Supervisory Board at WILEX AG, Chairman-Supervisory Board at Agennix AG, a Managing Director at Health Sciences GmbH & Co. KG, Chairman-Supervisory Board at InterComponentWare AG, Partner at RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB, a Managing Director at dievini Hopp BioTech holding GmbH & Co. KG, Chairman at Stiftung ProJustitia, a Managing Director at dievini Verwaltungs GmbH, a Managing Director at NewMarket Venture Verwaltungs GmbH, a Managing Director at RITTERSHAUS Management und Beteiligungs GmbH, a Managing Director at RITTERSHAUS Steuerberatungsgesellschaft mbH, Non-Executive Chairman at Febit, Inc., Chairman-Supervisory Board at SRH Holding GmbH, and Chairman-Supervisory Board at Hussel GmbH.
He is on the Board of Directors at AC Immune SA, LTS LOHMANN Therapie-Systeme AG, Nationaltheater Mannheim Foundation, Immatics Biotechnologies GmbH, and Franz Haniel & Cie.
GmbH.
Dr. Hettich was previously employed as Chairman-Supervisory Board by Actris AG, Chairman-Supervisory Board by J.F.
Müller & Sohn AG, Chairman-Supervisory Board by PARK & Bellheimer AG, Deputy Chairman-Supervisory Board by SYGNIS Pharma AG, a Managing Director by Bohlini GmbH & Co. KG, a Managing Director by Bohlini Verwaltungs GmbH, a Managing Director by Curacyte GmbH, a Managing Director by JUPEC Verlags GmbH, a Member-Supervisory Board by Eichbaum-Brauereien AG, a Member-Supervisory Board by Heidelberg Pharma AG, and a Member-Supervisory Board by SRH Kliniken GmbH.
He also served on the board at CureVac AG.
He received his undergraduate degree from the University of Freiburg, a graduate degree from the University of Freiburg, and a doctorate degree from Julius-Maximilians-Universität Würzburg.